Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Powell Says Would Be Ideal If Any Central Bank Digital Currency Had Authorizing Legislation From Congress

-Reuters

byBenzinga Newsdesk

September 28, 2021

1 minute read

-Reuters

Wells Fargo Upgrades Monte Rosa Therapeutics to Overweight, Announces $19 Price Target

By Benzinga Newsdesk

Today, 8:33 AM

Wells Fargo analyst Derek Archila upgrades Monte Rosa Therapeutics (NASDAQ:GLUE) from Equal-Weight to Overweight and announces $19 price target.

GLUE

Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $7

By Benzinga Newsdesk

Today, 8:33 AM

Telsey Advisory Group analyst Dana Telsey maintains Torrid Holdings (NYSE:CURV) with a Outperform and lowers the price target from $8 to $7.

CURV

Credit Suisse Maintains Outperform on Zscaler, Lowers Price Target to $310

By Benzinga Newsdesk

Today, 8:33 AM

Credit Suisse analyst Yaoxian Chew maintains Zscaler (NASDAQ:ZS) with a Outperform and lowers the price target from $410 to $310.

Medtronic Reports Received FDA Approval For Onyx Frontier Drug-Eluting Stent

By Benzinga Newsdesk

Today, 8:33 AM

The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13, 2022

MDT

Powell Says Would Be Ideal If Any Central Bank Digital Currency Had Authorizing Legislation From Congress

Related Posts

Wells Fargo Upgrades Monte Rosa Therapeutics to Overweight, Announces $19 Price Target

Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $7

Credit Suisse Maintains Outperform on Zscaler, Lowers Price Target to $310

Medtronic Reports Received FDA Approval For Onyx Frontier Drug-Eluting Stent